论文部分内容阅读
目的探讨ABO母儿血型不合的孕妇通过孕中晚期积极干预治疗与未治疗组其新生儿黄疸[2]发生率的关系。方法以在本院立卡产检,孕中期诊断为“母儿血型不合”的孕妇284例,随机分为两组,采用中西医结合治疗的208例为治疗组,孕期未治疗的76例为对照组,观察两组孕妇分娩的新生儿黄疸发生情况。结果治疗组有158例抗体效价降至正常,50例无效,治疗有效率为75.96%(158/208),治疗有效组与对照组及治疗无效组的新生儿黄疸发生率分别为5.70%、20.00%、15.79%(9/158,10/50,12/76)。有显著性差异(P<0.01),而对照组与治疗无效组新生儿黄疸的发生率无统计学差异(P>0.05)。结论孕中晚期通过对“母儿血型不合”孕妇的积极干预能有效降低新生儿黄疸的发生。
Objective To investigate the relationship between the incidence of neonatal jaundice [2] in non-treated and untreated pregnant women with positive ABO-incompatible pregnancies through the second trimester of pregnancy. Methods Totally 284 pregnant women diagnosed as risperidone in the second trimester of pregnancy were randomly divided into two groups: 208 cases treated with integrated traditional and western medicine, and 76 cases untreated during pregnancy For the control group, observe the incidence of neonatal jaundice in two groups of pregnant women. Results In the treatment group, the antibody titer of 158 patients was reduced to normal, and 50 patients were ineffective. The effective rate was 75.96% (158/208). The neonatal jaundice rates in the effective group, control group and ineffective group were 5.70% 20.00%, 15.79% (9/158, 10/50, 12/76). (P <0.01), while there was no significant difference in the incidence of neonatal jaundice between the control group and the ineffective group (P> 0.05). Conclusion The active intervention of pregnant women in the second trimester of pregnancy can effectively reduce the incidence of neonatal jaundice.